Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.
Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN.
Hurtado de Mendoza T, et al.
Nat Commun. 2021 Mar 9;12(1):1541. doi: 10.1038/s41467-021-21858-1.
Nat Commun. 2021.
PMID: 33750829
Free PMC article.